USP 800

The Pharmacy Times® USP 800 resource center provides clinical news and articles, information about practice and quality standards for handling hazardous drugs in health care settings; ways to promote safety safety for both workers and patients; and environmental protection.

What can we help you find?
[[thumbnail_alt_text]]
Steven C. Hoffart, PharmD, owner and operator of Magnolia Pharmacy in Magnolia, Texas, said his pharmacy had run out of prepared hand sanitizer when he saw a need for many people in his area.
[[thumbnail_alt_text]]
While not everything on this list is a law, they are all at least best practices and/or tips to most efficiently comply with a law or regulation, and to get your job done.
[[thumbnail_alt_text]]
Although they seem overwhelming, implementation of these best practices may improve long-term operational efficiency.
[[thumbnail_alt_text]]
A proposed FDA guidance could significantly impact veterinary practices and their ability to compound medicines for animal patients, according to a national survey.1
[[thumbnail_alt_text]]
The USP <800> is a set of practice and quality standards for handling hazardous drugs (HDs) developed by the USP as a part of a compendium of standards related to the compounding of drugs.
[[thumbnail_alt_text]]
Members of the former International Academy of Compounding Pharmacists voted in November 2019 to change the association’s name to the Alliance for Pharmacy Compounding.
[[thumbnail_alt_text]]
Those who handle hazardous drugs on a regular basis should follow steps to minimize exposure.
 
[[thumbnail_alt_text]]
Health System Pharmacists Should Think About the Implications of Acquiring and Dispensing These Compounded Products.
 
[[thumbnail_alt_text]]
According to the affiliation agreement, the Institute for Safe Medication Practices will be an ECRI Institute subsidiary when the transaction closes in January, 2020.
[[thumbnail_alt_text]]
The South Carolina business serves its community with compounding, medication adherence packaging, and free delivery and shipping.
[[thumbnail_alt_text]]
The FDA has awarded a cooperative agreement grant to the National Association of Boards of Pharmacy to develop a 3-year pilot project for a data-sharing system to improve oversight of compounding pharmacies.
 
[[thumbnail_alt_text]]
Two lawsuits against the FDA have been resolved in a conclusion favorable to Endo International, which argued that vasporessin should be excluded from the agency’s compounding list.